Alnylam Pharmaceuticals, Inc. (ALNY): $166.66

1.64 (+0.99%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ALNY to Watchlist
Sign Up

Industry: Biotech


Ranked

of 487

in industry

Alnylam Pharmaceuticals Inc (ALNY) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ALNY.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
18 $235 $90 $174.72 $150.46 16.12%

The Trend in the Analyst Price Target


Over the past 154 days, ALNY's average price target has gone up $10.76.

ALNY reports an average of 17.68% for its upside potential over the past 52 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-05 18 235 90 174.72 145.60 20%
2021-05-22 18 235 90 174.72 140.06 24.75%
2021-05-15 18 235 90 174.72 135.70 28.75%
2021-05-08 18 235 90 174.89 131.30 33.2%
2021-04-25 19 235 90 175.11 136.72 28.08%
2021-04-17 19 235 88 175.00 138.88 26.01%
2021-04-10 20 235 88 175.25 138.23 26.78%
2021-04-03 20 235 88 175.25 141.81 23.58%
2021-03-20 21 235 88 174.62 144.16 21.13%
2021-03-13 22 235 88 174.64 142.20 22.81%
2021-03-06 22 235 88 174.64 143.39 21.79%
2021-02-27 22 235 88 174.09 148.10 17.55%
2021-02-20 22 235 88 174.41 155.06 12.48%
2021-02-13 23 235 88 172.78 157.92 9.41%
2021-02-06 23 225 90 167.00 165.11 1.14%
2021-01-30 23 225 90 166.00 150.48 10.31%
2021-01-23 23 225 90 166.00 172.38 -3.7%
2021-01-16 23 225 90 166.00 166.36 -0.22%
2021-01-09 23 225 90 164.13 146.66 11.91%
2021-01-02 23 225 90 163.96 129.97 26.15%
2020-12-26 23 225 90 163.96 137.56 19.19%
2020-12-19 23 225 93 164.13 142.39 15.27%
2020-12-09 23 225 93 163.61 124.04 31.9%
2020-12-07 23 225 93 163.61 126.81 29.02%
2020-11-28 23 225 93 163.61 129.86 25.99%
2020-11-05 23 225 90 163.43 137.86 18.55%
2020-10-24 23 225 90 163.74 131.84 24.2%
2020-09-30 23 225 90 163.78 145.60 12.49%
2020-09-07 22 225 90 164.64 122.83 34.04%
2020-08-21 21 225 90 164.38 136.60 20.34%
2020-08-10 20 202 90 161.40 138.57 16.48%
2020-08-06 20 202 90 161.15 144.12 11.82%
2020-07-20 20 202 89 159.60 165.49 -3.56%
2020-07-14 20 202 89 158.45 157.23 0.78%
2020-06-27 21 202 74 152.57 151.90 0.44%
2020-06-05 21 202 74 152.00 NA NA%

ALNY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.64 3 9 9 0 0 21

The Trend in the Broker Recommendations


Over the past 30 weeks, ALNY's average broker recommendation rating worsened by 0.62.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Alnylam Pharmaceuticals Inc's average analyst price target is greater than 92.64% of all US stocks.
  • The number of analysts covering the stock of ALNY is greater than 95.97% of Pharmaceutical Products stocks.
  • ALNY has a less variance in analysts' estimates than 8.23% of all US stocks.
  • ALNY has a higher upside potential (average analyst target price relative to current price) than 14.84% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Alnylam Pharmaceuticals Inc are LLY, SGEN and SRPT.

Is ALNY a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9095 seconds.